An adequate iodine intake during pregnancy and lactation is important because both the foetus and the neonate are particularly vulnerable to the harmful effects of deficiency. The clinical consequences of severe iodine deficiency (ID) are easily recognised, but the effects of mild to moderate deficiency are often overlooked: thyroid enlargement in both the mother and the neonate, and hypothyroidism, hyperthyrotropinaemia and impaired neuropsychological development of the neonate 1 . In localities in which the iodine intake of the general population is adequate because of complete or partial salt iodisation programmes, the problem of ID in pregnant and lactating women, and hence in neonates, is minimal. Even in countries with a recently introduced but well-monitored salt iodisation programme, such as China, the goitre rate is low at about 5%, and the median urinary iodine (UI) concentrations of women of reproductive age and those who are pregnant and lactating indicate an adequate iodine nutrition 2 . This suggests that salt iodisation can prevent ID not only in schoolchildren, but also in pregnant mothers and their neonates. A randomised controlled study in China confirmed that infants born to mothers supplemented with iodised salt had significantly better gross motor function, language skills and development quotient, and that the percentage of infants born with a sub-normal development quotient was significantly lower than in controls 3 . A study in an area with an effective salt iodisation programme among the general population found that infants born with a concentration of thyroid-stimulating hormone (TSH) in cord blood of less than 5 mIU l 21 had significantly better mental and psychomotor development, better information processing skills and better cognitive development than infants with a cord blood TSH concentration above 10 mIU per l 4 . Apart from salt iodisation, other types of iodisation programmes can also be effective in preventing iodine deficiency disorders (IDD) in infants. For example, the iodisation of irrigation water in remote villages in Xinjang Province, China effectively and greatly reduced the neonatal and infant mortality rate 5, 6 . Similarly, iodised oil given orally to women prior to and during pregnancy decreased the total goitre rate and the percentage of infants born with abnormal intelligence when compared with a control group 7 . It is generally agreed that pregnant and lactating women require a greater iodine intake than non-pregnant women, and the ICCIDD, the UNICEF and the WHO recommend a daily intake of 200 mg 8 . As there is no reference indicator to define ID in pregnant and lactating women, it is difficult to monitor iodine status in both the pregnant mothers and their offspring. It has been reported that an intake of more than 1000 mg iodine per day by pregnant women can result in . However, it can be difficult to interpret the cord blood TSH concentration as it is affected by stress during delivery.
In places where there is no salt iodisation programme, it is uncertain whether the median UI concentration of schoolchildren and their total goitre rate can adequately reflect the iodine nutrition of other groups who may be at risk of deficiency, such as pregnant and lactating women. The experience in Hong Kong, where iodine intake is of marginal or borderline sufficiency, suggests that monitoring schoolchildren alone is not adequate to prevent ID in pregnant and lactating women and their offspring. In Hong Kong, a special administrative region in southern China, the median UI in schoolchildren was above 100 mg l 21 and less than 20% of urine samples had an iodine concentration below 50 mg per l 11, 12 . The total goitre rate among the schoolchildren was 3% 13 . These data suggest that schoolchildren in Hong Kong have an adequate iodine intake. However, neonatal screening has shown that the median cord blood TSH is 5.6 mIU l 21 and 22% of the cord blood samples had a TSH concentration of . 10 mIU per l 14 . The incidence of neonatal hypothyroidism was 1 in 3300 and 23% of cases of congenital hypothyroidism were transient in nature 14 . Cross-sectional and prospective studies of pregnant women in various trimesters of pregnancy in Hong Kong have revealed an increase in the UI concentration as pregnancy advances 15 . With a median UI of approximately 100-120 mg l 21 during the various stages of pregnancy, a significant percentage of women had a sub-normal serum thyroid hormone concentration at full term: 63% had a low free tri-iodothyronine concentration, 53% had a low thyroxine concentration and 5% had a low free thyroxine index. The thyroid gland was found to increase in volume by 30% during pregnancy and 25% of women had a gland size greater than 2 standard deviations of the mean size for non-pregnant southern Chinese women 15 . Pregnant women starting their second trimester with excessive thyroid stimulation, as shown by a high serum thyroglobulin concentration and a low free thyroxine concentration, had a low median UI and a large thyroid volume throughout their pregnancy. One half of the neonates born to these women had a sub-normal free thyroxine concentration at birth. It thus appears that a median UI of approximately 100 -120 mg l 21 during pregnancy is associated with maternal hypothyroxinaemia and thyroid enlargement, as well as hypothyroidism of neonates. Furthermore, women with excessive UI loss during pregnancy are more likely than others to develop new thyroid nodules during the second and third trimester of pregnancy 16 . In places without a salt iodisation programme, iodine supplementation of pregnant and lactating women and monitoring the UI concentration are necessary to prevent neonatal hypothyroidism and maternal goitrogenesis. Iodine supplements should ideally be given to women of reproductive age before conception to replenish their thyroid iodine store and thus ensure optimal early foetal brain development.
